News Focus
News Focus
Replies to #53642 on Biotech Values
icon url

DewDiligence

10/18/07 1:13 PM

#53643 RE: gym gravity #53642

VRTX – To frame genisi’s analysis in a single sentence: Boceprevir is Telaprevir’s #1 PI challenger (#msg-23085478).